Chao-Cheng Huang
闯辞产罢颈迟濒别： Professor
颁耻谤谤别苍迟闯辞产： Professor
贰-尘补颈濒： huangcc@cgmh.org.tw
笔丑辞苍别： 07-731-7123
贰诲耻肠补迟颈辞苍： Ph.D., Graduate Institute of Clinical Medicine Sciences, 91猫先生, Taiwan
贰虫辫别谤迟颈蝉别： Surgical Pathology, Gynecologic Pathology, Molecular Pathology, Head and Neck Pathology
Selected Publications (2018–2023)
1. Huang CC*, Kuo HM*, Wu PC, Cheng SH, Chang TT, Chang YC, Kung ML, Wu DC, Chuang JH, Tai MH. Soluble delta-like 1 homolog (DLK1) stimulates angiogenesis through Notch 1/Akt/eNOS signaling in endothelial cells. Angiogenesis 2018 May;21(2):299-312. (SCI) (*Co-first author)
2. Huang CC*, Cheng SH, Wu CH, Li WY, Wang JS, Kung ML, Chu TH, Huang ST, Feng CT, Huang SC, Tai MH*. Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling. Oncogene 2019 April;38:3201-3215. (SCI) (First author and *co-corresponding author)
3. Chen CM, Chu TH, Chou CC, Chien CY, Wang JS, Huang CC*. Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis. Oral Oncol 2021 Sep;120:105402. (SCI) (Corresponding author)
4. Chu TH, Chou YW, Lin SL, Lin SF, Chen HH, Hu WH, Chen YY, Chang-Chien GP, Chang JH, Tsai MC, Huang CC*. A pilot study examining the relationship between environmental contaminants and colorectal cancer at a single medical institute in Taiwan. Taiwan J Public Health 2021 Oct;40(4):382-393. (Corresponding author)
5. Wang CC, Huang KT, Chang HC, Tseng CC, Lai CH, Lan J, Liu TT, Huang CC*, Lin MC*. Comprehensive analysis of PD-L1 in non-small cell lung cancer with emphasis on survival benefit, impact of driver mutation and histological types, and archival tissue. Thorac Cancer 2022 Jan;13:38-47. (SCI) (Co-corresponding author)
6. Kuo TY, Huang CC, Shieh SJ, Wang YB, Lin MJ, Wu MC, Huang LLH. Skin wound healing assessment via an optimized wound array model in miniature pigs. Sci Rep 2022 Jan;12(1):445. (SCI)
7. Lee MG, Lee YK, Huang SC, Chang CL, Ko CY, Lee WC, Chen TY, Tzou SJ, Huang CY, Tai MH, Lin YW, Kung ML, Tsai MC, Chen YL, Chang YC, Wen ZH, Huang CC*, Chu TH*. DLK2 acts as a potential prognostic biomarker for clear cell renal cell carcinoma based on bioinformatics analysis. Genes 2022 Apr;13(4),629. (SCI) (Co-corresponding author)
8. Huang GK, Huang CC, Kang CH, Cheng YT, Tsai PC, Kao YH, Chung YH. Genetic interference of FGFR3 impedes invasion of upper tract urothelial carcinoma cells by alleviating RAS/MAPK signal activity. Int J Mol Sci 2023 Jan;24(2):1776. (SCI)
9. Wu JC, Huang CC, Wang PW, Chen TY, Hsu WM, Chuang JH, Chuang HC. ONC201 suppresses neuroblastoma growth by interrupting mitochondrial function and reactivating nuclear ATRX expression while decreasing MYCN. Int J Mol Sci 2023 Jan;24(2):1649. (SCI)
10. Huang SC*, Huang CC*, Ko CY, Huang CY, Liu CH, Lee YK, Chen TY, Hsueh CW, Tzou SJ, Tai MH, Hu TH, Tsai MC, Lee WC, Ho YC, Wu CC, Chang YC, Chang JJ, Liu KH, Li CC, Wen ZH, Chang CL, Chu TH. Slow skeletal muscle troponin T acts as a potential prognostic biomarker and therapeutic target for hepatocellular carcinoma. Gene 2023 May;865:147331. (SCI) (*Co-first author)